retatrutide phase 3 triumph just had its biggest data year yet. In 2026, Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist posted two major readouts: TRIUMPH-1 (obesity, 2,339 participants) showed a 28.3% average body weight Looking forward to when #retatrutide's

Semaglutide prescriptions are available online for weight loss at Klinic

As vendas de primeiros anlogos de GLP-1 brasileiros e a proximidade de quebra de patentes geram expectativa para aumento da produo nacional

Potassium supports heart and muscle function

How to choose the right needle or syringe size to minimize pain, avoid scar tissue buildup, and ensure a full dose every time you inject.

Here we talk about GLP-1 weight loss for women in perimenopause, as well as talk through GLP-1 side effects in women and microdosing GLP-1 benefits.

While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments